Jonathan M. Meyer, MD

Which treatment approaches are the state-of-the-art for helping this patient population?

The Metabolic Syndrome and Schizophrenia: Clinical Research Update

The atypical antipsychotics have become the treatment of choice for patients with psychotic and other behavioral disorders. However, case reports, retrospective studies and epidemiological data suggest that these medications may be associated with new-onset type 2 diabetes and diabetic ketoacidosis.